Sidvim LifeSciences Private Limited

  Contents Very brief analysis of Exports of Cadila. General information Change in Data Exclusivity for Pharmaceutical Products in the United Arab Emirates Nigerian drug regulator blacklists Gujarat pharma company for ‘substandard’ antibiotics Intellectual Property Very brief analysis of Exports of Cadila. Last few weeks we are following Cadila Healthcare. We analysed their patent portfolio. We studied their import data; we reported about their probable development pipeline. Today we are analysing exports of   Cadila and arrived at some very interesting finding. To start with, few graphs about commercial information about exports Top oversees customers of Cadila Top export countries by volume Top 25 Exports of Cadila: 1.       Nebivolol and Amlodipine are among top exports. 2.       Most of top 10 exports is to trader in Ireland. 3.       US is top export by Value but far less in volume.   SIDVIM view: The main objective of this Newsletter is

Contents:  A brief analysis of imports of Cadila Healthcare and inferences about their development pipeline. General information.  Understanding the Importance of Crystallization Processes   Regulatory Compliance Trends Intellectual Property. Everolimus USA   A brief analysis of imports of Cadila Healthcare and inferences about their development pipeline Last week we analysed the patent portfolio of Cadila Healthcare. Here, we have tried to dig out some insights from the imports of Cadila Healthcare. As expected, maximum import is from China, followed by Germany, Italy, and USA. This is no brainer since every Indian Gx company imports from China. We tried to evaluate the current development pipeline of Cadila Healthcare by analysing its imports. In a very brief analysis of company’s imports during last 4-5 months, we discovered the following: Intermediate imported by Cadila Quantity in KGs FDA Approval date SIDVIM Comment